Order

Hydrogen and health / Research review

Hydrogen and lungs exposed to dust: smog, pneumoconiosis, interstitial lung disease

Three randomised trials concern people whose lungs are burdened by dust or fibrosis. After a month of inhalation, workers exposed to smog coughed less, and in silicosis the authors observed a better diffusing capacity of the lungs when hydrogen was added to treatment.

Covers

  • smog
  • silicosis
  • interstitial lung disease
  • cough

Studies

Human studies: 3 studies in the cards below, including 3 randomised.

How hydrogen was given

Inhalation, hydrogen water.

On this page

Smog and pneumoconiosis: key findings from the studies

  • Workers exposed to polluted air: after 30 days of inhalation, less coughing, lower inflammatory markers and slightly higher FEV₁.
  • Silicosis (108 people): better diffusing capacity of the lungs and less breathlessness with hydrogen added to the medicine.
  • Early interstitial lung disease: improvement on CT in 73.0% of people who completed 48 weeks of drinking hydrogen water versus 39.5% in the comparison group.

Hydrogen and smog: a study of workers exposed to polluted air

96 municipal service workers breathed a hydrogen-oxygen mixture or a nitrogen-oxygen mixture for an hour a day1. After 30 days the hydrogen group reported less coughing, had lower selected inflammatory markers and an FEV₁ of about 97% versus 95% of the predicted value. The clearest changes were in coughing and some of the inflammatory markers.

Hydrogen, pneumoconiosis and interstitial lung disease

In a study of 108 people with stage II silicosis, the authors observed a greater improvement in the diffusing capacity of the lungs and in breathlessness with hydrogen inhalation added to tetrandrine than with the medicine alone2. Here hydrogen was an add-on to the medicine.

In early interstitial lung disease, 48 weeks of drinking hydrogen water were compared with N-acetylcysteine3. Among the people who completed the study, 73.0% showed improvement on CT versus 39.5% (p=0.008).

Hydrogen and smog and pneumoconiosis: the studies we refer to

Click an entry to see who took part in the study, how hydrogen was given and what the result was.

What the studies say

Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.

1

Effects of smog exposure in municipal workers

randomised trialn = 96inhalation2016
Participants
Workers exposed to air pollution
Protocol
H2/O2 66.67%/33.33% vs N₂/O2, 1 h/day for 30 days
Result
Less coughing and lower selected inflammatory markers. On day 30, FEV₁ was about 97% vs 95% of the predicted value (p<0.05).
Study context
RCT, double-blind. Participants: 96.

Gong ZJ i wsp.. [Protective effect of hydrogen on the lung of sanitation workers exposed to haze]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 39(12): 916-923. 2016. PubMed 27938540 · DOI

2

Stage II silicosis

randomised trialn = 108inhalation2026
Participants
116 enrolled; 54 H2 + tetrandrine and 54 tetrandrine alone in the analysis
Protocol
H2 as an addition to tetrandrine; comparison with the medicine alone
Result
The combination improved the diffusing capacity of the lungs and breathlessness; IL-6 was lower than with the medicine alone (p<0.05).
Study context
RCT, double-blind. Participants: 108.

Xiao K i wsp.. The clinical efficacy of hydrogen combined with tetrandrine in the treatment of silicosis fibrosis: A randomized controlled intervention study. Respiratory medicine 260: 108939. 2026. PubMed 42250702 · DOI

3

Early interstitial lung disease

Hydrogen waterrandomised trialn = 872023
Participants
44 H2 and 43 NAC in the ITT analysis; 75 completed the protocol
Protocol
350 ml of H2 at 1.6 ppm 2× a day for 48 weeks vs NAC
Result
More favourable CPI and DLCO. HRCT improvement: 63.6% vs 39.5% in the ITT analysis; among those completing the protocol 73.0% vs 39.5% (p=0.008).
Study context
Randomised controlled trial. Participants: 87.

Tang C i wsp.. Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial. Therapeutics and clinical risk management 19: 1051-1061. 2023. PubMed 38107500 · DOI · Full text

Educational information, not medical advice. Full database of publications: Hydrogen Studies.

Smog and pneumoconiosis: topics in this area

Smog and pneumoconiosis and hydrogen: frequently asked questions

How was hydrogen given in the smog and pneumoconiosis studies?

Workers exposed to polluted air breathed a hydrogen-oxygen mixture for one hour a day for 30 days. In silicosis, inhalation was added to a medicine, and in early interstitial lung disease participants drank 350 ml of hydrogen water twice a day for 48 weeks.

What changed after a month of inhalation in people exposed to smog?

After 30 days the hydrogen group reported less coughing and had lower levels of selected inflammation markers. FEV₁ was about 97% of the predicted value, compared with 95% in the comparison group.

Is it a medical device?

No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.

Is hydrogen inhalation safe?

In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.

See also